Results
|
1161.
|
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. [electronic resource] by
- Uher, Tomas
- Blahova-Dusankova, Jana
- Horakova, Dana
- Bergsland, Niels
- Tyblova, Michaela
- Benedict, Ralph H B
- Kalincik, Tomas
- Ramasamy, Deepa P
- Seidl, Zdenek
- Hagermeier, Jesper
- Vaneckova, Manuela
- Krasensky, Jan
- Havrdova, Eva
- Zivadinov, Robert
Producer: 20151109
In:
Journal of neurology vol. 261
Availability: No items available.
|
|
1162.
|
|
|
1163.
|
|
|
1164.
|
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. [electronic resource] by
- Schippling, Sven
- O'Connor, Paul
- Knappertz, Volker
- Pohl, Christoph
- Bogumil, Timon
- Suarez, Gustavo
- Cook, Stuart
- Filippi, Massimo
- Hartung, Hans-Peter
- Comi, Giancarlo
- Jeffery, Douglas R
- Kappos, Ludwig
- Goodin, Douglas S
- Arnason, Barry
Producer: 20170407
In:
Journal of neurology vol. 263
Availability: No items available.
|
|
1165.
|
Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study. [electronic resource] by
- Dattola, Vincenzo
- Bonanno, Lilla
- Naro, Antonino
- Chillura, Antonino
- Logiudice, Anna Lisa
- Sessa, Edoardo
- Famà, Fausto
- Quartarone, Angelo
- Calabrò, Rocco Salvatore
- Marino, Silvia
- Russo, Margherita
Producer: 20180607
In:
BioMed research international vol. 2017
Availability: No items available.
|
|
1166.
|
|
|
1167.
|
[Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression]. [electronic resource] by
- Oentrich, W
- Dose, T
- Friedmann, D
- Haupts, M
- Haller, P
- Hartung, H P
- Walther, E U
- König, N
- Schröder, G
- Stürzebecher, C S
Producer: 20010607
In:
Der Nervenarzt vol. 72
Availability: No items available.
|
|
1168.
|
|
|
1169.
|
|
|
1170.
|
|
|
1171.
|
|
|
1172.
|
|
|
1173.
|
|
|
1174.
|
|
|
1175.
|
|
|
1176.
|
|
|
1177.
|
Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. [electronic resource] by
- Coles, Alasdair J
- Fox, Edward
- Vladic, Anton
- Gazda, Suzanne K
- Brinar, Vesna
- Selmaj, Krzysztof W
- Bass, Ann Doan-Do
- Wynn, Daniel R
- Margolin, David H
- Lake, Stephen L
- Moran, Susan
- Palmer, Jeffrey
- Smith, M Shelton
- Compston, D Alastair S
Producer: 20110615
In:
The Lancet. Neurology vol. 10
Availability: No items available.
|
|
1178.
|
|
|
1179.
|
|
|
1180.
|
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. [electronic resource] by
- Cohen, Jeffrey A
- Coles, Alasdair J
- Arnold, Douglas L
- Confavreux, Christian
- Fox, Edward J
- Hartung, Hans-Peter
- Havrdova, Eva
- Selmaj, Krzysztof W
- Weiner, Howard L
- Fisher, Elizabeth
- Brinar, Vesna V
- Giovannoni, Gavin
- Stojanovic, Miroslav
- Ertik, Bella I
- Lake, Stephen L
- Margolin, David H
- Panzara, Michael A
- Compston, D Alastair S
Producer: 20121210
In:
Lancet (London, England) vol. 380
Availability: No items available.
|